Recently, our team was honoured to attend the World Orphan Drug Congress USA in Boston. The event brought together key stakeholders, experts, and industry leade...
Continue reading
Parkinson's disease (PD) is a complex neurodegenerative disorder driven by a combination of genetic and environmental factors. While most cases cannot be attrib...
Continue reading
In precision medicine trials, DNA sequencing is not a background step. It determines eligibility, shapes enrollment pathways, and directly influences the qualit...
Continue reading
Over the past year, Sano and BenevolentAI have collaborated to demonstrate how an integrated, decentralized platform — combining patient recruitment, at-home ge...
Continue reading
National DNA Day, observed on April 25th, commemorates the discovery of the double helix structure of DNA. It’s an annual, global celebration – and this year, i...
Continue reading
This webinar, hosted by Patrick Short of Sano Genetics and featuring Wayne Eskridge and Dr. Neeraj Mistry focussed on the non-invasive screening and genomics in...
Continue reading
This webinar was hosted by Paul Wicks and featured Sano CEO Patrick Short, Rakhi Rajani from Genomics England, and Julian Hastings Ward who chairs the participa...
Continue reading
Genetic testing has expanded significantly, both in clinical contexts and beyond. Understanding the distinctions between testing modalities—genotyping, targeted...
Continue reading
Advances in large-scale genome sequencing, data storage, and analysis are accelerating the development of precision medicine across a growing number of therapeu...
Continue reading
Polygenic risk scores enable clinicians and researchers to stratify patient populations by genetic risk, informing decisions on screening schedules, therapeutic...
Continue reading